NO20062860L - Sammensetning og fremgangsmate for styrking av biologisk tilgjengelighet - Google Patents
Sammensetning og fremgangsmate for styrking av biologisk tilgjengelighetInfo
- Publication number
- NO20062860L NO20062860L NO20062860A NO20062860A NO20062860L NO 20062860 L NO20062860 L NO 20062860L NO 20062860 A NO20062860 A NO 20062860A NO 20062860 A NO20062860 A NO 20062860A NO 20062860 L NO20062860 L NO 20062860L
- Authority
- NO
- Norway
- Prior art keywords
- composition
- enhancing bioavailability
- bioavailability
- enhancing
- compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000002708 enhancing effect Effects 0.000 title 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
En foreliggende oppfinnelsen vedrører sammensetninger og fremgangsmåter for økning av den biologiske tilgjengeligheten av fordelaktige midler med vannløselighet.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52342103P | 2003-11-19 | 2003-11-19 | |
US10/984,401 US20050181049A1 (en) | 2003-11-19 | 2004-11-09 | Composition and method for enhancing bioavailability |
PCT/US2004/037927 WO2005051358A1 (en) | 2003-11-19 | 2004-11-12 | Composition and method for enhancing bioavailability |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20062860L true NO20062860L (no) | 2006-08-17 |
Family
ID=34636467
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20062860A NO20062860L (no) | 2003-11-19 | 2006-06-19 | Sammensetning og fremgangsmate for styrking av biologisk tilgjengelighet |
Country Status (13)
Country | Link |
---|---|
US (1) | US20050181049A1 (no) |
EP (1) | EP1684726A4 (no) |
JP (1) | JP2007511608A (no) |
KR (1) | KR20060109934A (no) |
AR (1) | AR048017A1 (no) |
AU (1) | AU2004292415A1 (no) |
CA (1) | CA2546618A1 (no) |
IL (1) | IL175647A0 (no) |
MX (1) | MXPA06005630A (no) |
NO (1) | NO20062860L (no) |
PE (1) | PE20050584A1 (no) |
TW (1) | TW200529884A (no) |
WO (1) | WO2005051358A1 (no) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9808052D0 (en) | 1998-04-17 | 1998-06-17 | Secr Defence | Implants for administering substances and methods of producing implants |
PL2316456T3 (pl) | 2003-04-29 | 2017-12-29 | Orexigen Therapeutics, Inc. | Kompozycje wpływające na utratę masy zawierające antagonistę opioidów i bupropion |
MX2007004973A (es) * | 2004-10-25 | 2007-06-14 | Japan Tobacco Inc | Formulacion solida con solubilidad y estabilidad mejoradas y metodo para producir la formulacion. |
ZA200704246B (en) * | 2004-10-25 | 2009-09-30 | Japan Tobacco Inc | Solid medicinal preparation improved in solubility and stability and process for producing the same |
ES2669585T3 (es) | 2004-10-29 | 2018-05-28 | The Regents Of The University Of California | Micropartículas porosas de silicio para la entrega de fármaco para el ojo |
US20070009589A1 (en) * | 2005-07-07 | 2007-01-11 | Kandarapu Raghupathi | Extended release compositions |
WO2007041079A2 (en) * | 2005-09-30 | 2007-04-12 | Alza Corporation | Banded controlled release nanoparticle active agent formulation dosage forms and methods |
DK2135603T3 (da) | 2005-11-22 | 2013-03-25 | Orexigen Therapeutics Inc | Sammensætninger og fremgangsmåder til øgning af insulinsensitivitet |
ES2383330T3 (es) * | 2005-11-28 | 2012-06-20 | Orexigen Therapeutics, Inc. | Formulación de liberación sostenida de zonisamida |
AU2007203715B2 (en) * | 2006-01-05 | 2012-08-02 | Veloxis Pharmaceuticals A/S | Disintegrating loadable tablets |
US8916195B2 (en) | 2006-06-05 | 2014-12-23 | Orexigen Therapeutics, Inc. | Sustained release formulation of naltrexone |
WO2008060964A2 (en) | 2006-11-09 | 2008-05-22 | Orexigen Therapeutics, Inc. | Unit dosage package and methods for administering weight loss medications |
US8088786B2 (en) | 2006-11-09 | 2012-01-03 | Orexigen Therapeutics, Inc. | Layered pharmaceutical formulations |
DE102006054638B4 (de) * | 2006-11-16 | 2014-12-04 | Laburnum Gmbh | Pharmazeutische Einzeldosisform |
US8399007B2 (en) | 2006-12-05 | 2013-03-19 | Landec Corporation | Method for formulating a controlled-release pharmaceutical formulation |
WO2008070118A1 (en) | 2006-12-05 | 2008-06-12 | Landec Corporation | Drug delivery |
GB0709541D0 (en) * | 2007-05-17 | 2007-06-27 | Jagotec Ag | Pharmaceutical excipient |
FR2918277B1 (fr) * | 2007-07-06 | 2012-10-05 | Coretecholding | Nouveau procede de production de formes pharmaceutiques seches hydrodispersibles et les compositions hydrodispersibles ainsi obtenues |
KR20170084358A (ko) * | 2007-07-10 | 2017-07-19 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 선택된 조직에 조성물을 전달하는 물질 및 방법 |
US20090035370A1 (en) * | 2007-08-02 | 2009-02-05 | Drugtech Corporation | Dosage form and method of use |
US8114883B2 (en) | 2007-12-04 | 2012-02-14 | Landec Corporation | Polymer formulations for delivery of bioactive materials |
US20110144145A1 (en) | 2008-05-30 | 2011-06-16 | Orexigen Therapeutics, Inc. | Methods for treating visceral fat conditions |
EP2135601A1 (en) * | 2008-06-20 | 2009-12-23 | Capsulution Nanoscience AG | Stabilization of amorphous drugs using sponge-like carrier matrices |
CN102341096B (zh) | 2009-03-04 | 2015-02-18 | 奥瑞克索股份公司 | 新型抗滥用制剂 |
CA2758607C (en) | 2009-05-04 | 2018-05-15 | Psivida Us, Inc. | Porous silicon drug-eluting particles |
CN102421419B (zh) | 2009-05-08 | 2016-05-04 | 奥瑞克索股份公司 | 用于持续药物传递的包含地聚合物粘合剂的组合物 |
EP2440192A4 (en) * | 2009-06-11 | 2013-08-28 | Landec Corp | COMPOSITIONS AND METHODS FOR ADMINISTERING MATERIALS |
US9248123B2 (en) | 2010-01-11 | 2016-02-02 | Orexigen Therapeutics, Inc. | Methods of providing weight loss therapy in patients with major depression |
KR20140003405A (ko) | 2010-09-07 | 2014-01-09 | 오렉쏘 에이비 | 경피 약물 투여 장치 |
JP6026424B2 (ja) | 2010-11-01 | 2016-11-16 | シヴィダ・ユーエス・インコーポレイテッドPsivida Us, Inc. | 治療薬送達のための生物浸食性ケイ素ベースのデバイス |
US9394369B2 (en) | 2011-01-03 | 2016-07-19 | The Regents Of The University Of California | Luminescent porous silicon nanoparticles for targeted delivery and immunization |
ES2802048T3 (es) | 2012-06-06 | 2021-01-15 | Nalpropion Pharmaceuticals Llc | Composición para uso en un método para el tratamiento de sobrepeso y obesidad en pacientes con alto riesgo cardiovascular |
US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
AU2014235051B2 (en) | 2013-03-15 | 2019-01-17 | Eyepoint Pharmaceuticals Us, Inc. | Bioerodible silicon-based compositions for delivery of therapeutic agents |
WO2017008059A1 (en) | 2015-07-09 | 2017-01-12 | The Regents Of The University Of California | Fusogenic liposome-coated porous silicon nanoparticles |
WO2019113079A1 (en) | 2017-12-05 | 2019-06-13 | Sunovion Pharmaceuticals Inc. | Nonracemic mixtures and uses thereof |
JP2021505595A (ja) | 2017-12-05 | 2021-02-18 | サノビオン ファーマシューティカルズ インクSunovion Pharmaceuticals Inc. | 結晶形およびその製造方法 |
SG11202113266YA (en) | 2019-06-04 | 2021-12-30 | Sunovion Pharmaceuticals Inc | Modified release formulations and uses thereof |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06511481A (ja) * | 1991-07-05 | 1994-12-22 | ユニバーシティ オブ ロチェスター | 気泡を取り込む超微小非凝集多孔質粒子 |
JP2700141B2 (ja) * | 1993-09-17 | 1998-01-19 | 富士化学工業株式会社 | リン酸水素カルシウム及びその製法並びにそれを用いた賦形剤 |
US5633011A (en) * | 1994-08-04 | 1997-05-27 | Alza Corporation | Progesterone replacement therapy |
US5885616A (en) * | 1997-08-18 | 1999-03-23 | Impax Pharmaceuticals, Inc. | Sustained release drug delivery system suitable for oral administration |
SE512958C2 (sv) * | 1998-04-30 | 2000-06-12 | Triple Crown Ab | Kolesterolsänkande komposition innehållande beta-sitosterol och/eller beta-sitostanol samt förfarande för dess framställning |
JP4027535B2 (ja) * | 1998-05-26 | 2007-12-26 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 脂溶性薬物を含有した粉末 |
US6174547B1 (en) * | 1999-07-14 | 2001-01-16 | Alza Corporation | Dosage form comprising liquid formulation |
EP1140012B1 (en) * | 1998-12-17 | 2004-03-03 | Alza Corporation | Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings |
US6342249B1 (en) * | 1998-12-23 | 2002-01-29 | Alza Corporation | Controlled release liquid active agent formulation dosage forms |
US6395300B1 (en) * | 1999-05-27 | 2002-05-28 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
US6793934B1 (en) * | 1999-12-08 | 2004-09-21 | Shire Laboratories, Inc. | Solid oral dosage form |
US6720003B2 (en) * | 2001-02-16 | 2004-04-13 | Andrx Corporation | Serotonin reuptake inhibitor formulations |
ES2739023T3 (es) * | 2001-07-06 | 2020-01-28 | Veloxis Pharmaceuticals As | Aglomeración controlada |
US20050175689A1 (en) * | 2003-10-27 | 2005-08-11 | Yamanouchi Pharmaceutical Co., Ltd. | Coated fine particles containing drug for intrabuccally fast disintegrating tablet |
-
2004
- 2004-11-09 US US10/984,401 patent/US20050181049A1/en active Pending
- 2004-11-12 WO PCT/US2004/037927 patent/WO2005051358A1/en active Application Filing
- 2004-11-12 EP EP04810907A patent/EP1684726A4/en not_active Withdrawn
- 2004-11-12 CA CA002546618A patent/CA2546618A1/en not_active Abandoned
- 2004-11-12 MX MXPA06005630A patent/MXPA06005630A/es unknown
- 2004-11-12 JP JP2006541279A patent/JP2007511608A/ja not_active Withdrawn
- 2004-11-12 KR KR1020067011779A patent/KR20060109934A/ko not_active Application Discontinuation
- 2004-11-12 AU AU2004292415A patent/AU2004292415A1/en not_active Abandoned
- 2004-11-18 PE PE2004001132A patent/PE20050584A1/es not_active Application Discontinuation
- 2004-11-18 TW TW093135330A patent/TW200529884A/zh unknown
- 2004-11-19 AR ARP040104283A patent/AR048017A1/es not_active Application Discontinuation
-
2006
- 2006-05-15 IL IL175647A patent/IL175647A0/en unknown
- 2006-06-19 NO NO20062860A patent/NO20062860L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20050181049A1 (en) | 2005-08-18 |
MXPA06005630A (es) | 2006-12-14 |
IL175647A0 (en) | 2006-09-05 |
WO2005051358A1 (en) | 2005-06-09 |
AR048017A1 (es) | 2006-03-22 |
WO2005051358A8 (en) | 2005-07-21 |
PE20050584A1 (es) | 2005-08-15 |
TW200529884A (en) | 2005-09-16 |
CA2546618A1 (en) | 2005-06-09 |
EP1684726A4 (en) | 2007-10-03 |
KR20060109934A (ko) | 2006-10-23 |
EP1684726A1 (en) | 2006-08-02 |
AU2004292415A1 (en) | 2005-06-09 |
JP2007511608A (ja) | 2007-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20062860L (no) | Sammensetning og fremgangsmate for styrking av biologisk tilgjengelighet | |
CO5611137A2 (es) | Composiciones de clorhidrato de naltrexona | |
EA201000642A1 (ru) | 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы | |
EA201200669A1 (ru) | ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα | |
EA200800760A1 (ru) | ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα | |
TNSN05254A1 (en) | Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics | |
DE602004024572D1 (de) | Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen | |
MY153424A (en) | Modulators of indoleamine 2,3-dioxygenase and methods of using the same | |
BRPI0414599A (pt) | pirrol-indóis substituìdos | |
DE602004014117D1 (de) | Thiazole zur verwendung als inhibitoren von protein-kinasen | |
EA200601391A1 (ru) | Производные хинолина для применения в качестве микобактериальных ингибиторов | |
EA200701306A1 (ru) | Лиофилизация виросом | |
EA200501928A1 (ru) | Пирролодигидроизохинолины как ингибиторы pde10 | |
ATE412649T1 (de) | Substituierte heteroarylbenzofuransäuren | |
ES2311803T3 (es) | Composiciones embolicas de silicie pirogena. | |
NO20062699L (no) | Smelteblandingsdispergeringer | |
CY1109992T1 (el) | Παραγωγα του αλφα-αμιναμιδιου χρησιμα ως αντιφλεγμονωδη μεσα | |
EA200700400A1 (ru) | Производные n-(1h-индолил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии | |
NO20060535L (no) | Aztreonam-L-lysin og fremgangsmater for fremstilling av dette | |
NO20071805L (no) | Alkylidentetrahydronaftalenderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere. | |
ATE363474T1 (de) | Benzimidazole zur behandlung sexueller fehlfunktionen | |
EA200701852A1 (ru) | Производные аминокислот | |
MX2008001541A (es) | Metodos para la preparacion de inhibidores de polimerasa del vhc. | |
ATE443044T1 (de) | Tace inhibitoren | |
ATE419242T1 (de) | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |